Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Neutral
Price to Earnings Rating
Strong Sell
Analyst Rating
Sell
Wall Street Data Solutions Rating
Neutral
B
ATAI Life Sciences N.V. Common Shares (ATAI)
Pharmaceutical Preparations
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.
WALLSTRASSE 16
BERLIN, 2M
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
06/18/2021
Market Cap
207,231,765
Shares Outstanding
166,010,000
Weighted SO
166,010,476
Total Employees
N/A
Upcoming Earnings
08/08/2024
Beta
0.8080
Last Div
0.0000
Range
1.025-2.85
Chg
-0.0150
Avg Vol
838332
Mkt Cap
207231765
Exch
NASDAQ
Country
DE
Phone
49 89 2153 9035
DCF Diff
1.0788
DCF
0.1713
Div Yield
0.0000
P/S
548.2322
EV Multiple
-1.7341
P/FV
1.1798
Div Yield %
0.0000
P/E
-3.4109
PEG
-0.0470
Payout
0.0000
Current Ratio
6.6826
Quick Ratio
6.6826
Cash Ratio
1.9459
DSO
11660.6878
DIO
0.0000
Op Cycle
11660.6878
DPO
4094.4412
CCC
7566.2467
Gross Margin
0.1005
Op Margin
-291.2937
Pretax Margin
-152.4127
Net Margin
-153.6323
Eff Tax Rate
-0.0052
ROA
-0.2691
ROE
-0.2582
ROCE
-0.5557
NI/EBT
1.0080
EBT/EBIT
0.5232
EBIT/Rev
-291.2937
Debt Ratio
0.0776
D/E
0.0997
LT Debt/Cap
0.0895
Total Debt/Cap
0.0907
Int Coverage
-80.8436
CF/Debt
-4.6687
Equity Multi
1.2852
Rec Turnover
0.0313
Pay Turnover
0.0891
Inv Turnover
0.0000
FA Turnover
0.1973
Asset Turnover
0.0018
OCF/Share
-0.4874
FCF/Share
-0.4875
Cash/Share
0.6444
OCF/Sales
-206.8192
FCF/OCF
1.0002
CF Coverage
-4.6687
ST Coverage
-327.1032
CapEx Coverage
-4594.0882
Div&CapEx Cov
-4594.0882
P/BV
1.1798
P/B
1.1798
P/S
548.2322
P/E
-3.4109
P/FCF
-2.6502
P/OCF
-2.5337
P/CF
-2.5337
PEG
-0.0470
P/S
548.2322
EV Multiple
-1.7341
P/FV
1.1798
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Dividend History
Cash Value | Ex-Dividend Date | Declaration Date | Record Date | Pay Date |
---|---|---|---|---|
6.00 | 08/27/2018 | 08/08/2018 | 08/20/2018 | 11/30/-0001 |
0.39 | 06/08/2017 | 06/01/2017 | 06/12/2017 | 06/15/2017 |
0.39 | 06/26/2014 | 05/29/2014 | 06/30/2014 | 07/18/2014 |
0.15 | 08/16/2012 | 11/30/-0001 | 11/30/-0001 | 09/20/2012 |
0.43 | 06/28/2011 | 06/08/2011 | 11/30/-0001 | 08/01/2011 |